Aurobindo Pharmaceuticals

Rediff.com » News » Aurobindo Pharmaceuticals

News for Aurobindo Pharmaceuticals

News
Business
Sports

How companies show electoral donations in annual reports

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......

More Covid vaccine candidates get approval for clinical trials in India

Ahmedabad-based Zydus Cadila, Bharat Biotech’s intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.......

Can MFN Pricing Reshape India-US Pharma Equation?

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent). Illustration: Uttam......

Indian Pharma Gets Relief from Trump's Tariffs

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with......

India Inc holds breath for Trump's new tariffs to kick in

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.......

Aurobindo Pharma: Strong prospects offset by valuation concerns

Since the start of this financial year (FY24), the stock of Aurobindo Pharma has been one of the top pharma gainers, enhancing investor wealth by over 68 per cent, with a third of those gains......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

Adani, Goenka could lead the charge at IPL team bidding

IMAGE: There are 22 companies which have picked up tender document worth Rs 10 lakh but with base price for new teams pegged at Rs 2000 crore,......

Aurobindo Pharmaceuticals

News for Aurobindo Pharmaceuticals

How companies show electoral donations in annual reports

More Covid vaccine candidates get approval for clinical trials in India

Can MFN Pricing Reshape India-US Pharma Equation?

Indian Pharma Gets Relief from Trump's Tariffs

India Inc holds breath for Trump's new tariffs to kick in

Aurobindo Pharma: Strong prospects offset by valuation concerns

Lower input costs may aid pharma firms' Q2 margins

Adani, Goenka could lead the charge at IPL team bidding

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS